# FDA Inspection 1178110 - Continental Services Group, Inc. - August 24, 2022

Source: https://www.keypedia.com/records/fda_inspections/continental-services-group-inc/59c7d5d1-6a5a-46ac-8e84-bca592b6933b
Source feed: FDA_Inspections

> FDA Inspection 1178110 for Continental Services Group, Inc. on August 24, 2022. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1178110
- Company Name: Continental Services Group, Inc.
- Inspection Date: 2022-08-24
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1178110 - 2022-08-24](https://www.keypedia.com/records/fda_inspections/continental-services-group-inc/863a919f-b7c6-4ee1-a12f-df26270d21cb)
- [FDA Inspection 1096414 - 2019-07-09](https://www.keypedia.com/records/fda_inspections/continental-services-group-inc/0506e847-6917-4d56-baf8-a6a0a19814fa)
- [FDA Inspection 1023396 - 2017-08-22](https://www.keypedia.com/records/fda_inspections/continental-services-group-inc/7f1d4708-484f-4a85-b019-598b8d1f7b0f)

Company: https://www.keypedia.com/companies/continental-services-group-inc/6a7a7180-4020-4fc8-a2f2-ca4ab032c3a4

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d